Optimized protocol to create deletion in adherent cell lines using CRISPR/Cas9 system.


Journal

STAR protocols
ISSN: 2666-1667
Titre abrégé: STAR Protoc
Pays: United States
ID NLM: 101769501

Informations de publication

Date de publication:
17 12 2021
Historique:
entrez: 8 11 2021
pubmed: 9 11 2021
medline: 9 11 2021
Statut: epublish

Résumé

The CRISPR/Cas9 system is a powerful tool for genome editing and is adaptable for a wide range of applications. Here, we have put together a step-by-step protocol for generating knockout cell lines (coding or non-coding region) using CRISPR/Cas9 tool. The protocol below has been tested on adherent cell lines such as HeLa and MCF7. However, it may easily be adapted to other adherent cell lines with minor variations. For complete details on the use and execution of this protocol, please refer to Farooq et al. (2021).

Identifiants

pubmed: 34746853
doi: 10.1016/j.xpro.2021.100857
pii: S2666-1667(21)00563-3
pmc: PMC8551220
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

100857

Informations de copyright

© 2021 The Authors.

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

Nat Methods. 2013 Oct;10(10):977-9
pubmed: 23892898
Nucleic Acids Res. 2018 Jul 2;46(W1):W242-W245
pubmed: 29762716
Nat Commun. 2018 May 15;9(1):1911
pubmed: 29765029
Cell Rep. 2021 Mar 23;34(12):108898
pubmed: 33761351
Cell. 2013 Jul 18;154(2):442-51
pubmed: 23849981
Nat Commun. 2017 Mar 14;8:14725
pubmed: 28290446
Elife. 2013 Jan 29;2:e00471
pubmed: 23386978
Cell. 2016 Sep 22;167(1):219-232.e14
pubmed: 27662090

Auteurs

Umer Farooq (U)

National Centre for Biological Sciences, Tata Institute for Fundamental Research, Bangalore, Karnataka 560065, India.
The University of Trans-Disciplinary Health Sciences and Technology, IVRI road, Bangalore, Karnataka 560064, India.

Dimple Notani (D)

National Centre for Biological Sciences, Tata Institute for Fundamental Research, Bangalore, Karnataka 560065, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH